HER2 Positive Breast Cancers with Progression

被引：0
|
作者：
Solanki, Malvika [1 ]
Chitambar, Christopher [2 ]
Jorns, Julie [3 ]
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Med Coll Wisconsin, Affiliated Hosp, Milwaukee, WI 53226 USA
[3] Med Coll Wisconsin, Milwaukee, WI 53226 USA
来源：
LABORATORY INVESTIGATION | 2019年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
259
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Are Thyroid Hormone and Tumor Cell Proliferation in Human Breast Cancers Positive for HER2 Associated?
    Mourouzis, Iordanis
    Tzovaras, Alexandros
    Armonis, Basil
    Ardavanis, Alexandros
    Skondra, Maria
    Misitzis, John
    Pectasides, Demetrios
    Pantos, Constantinos
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2015, 2015
  • [32] 'A putative role for bone morphogenetic protein antagonist Gremlin in HER2 positive breast cancers'
    Zabkiewicz, Catherine
    Hargest, Rachel
    Ye, Lin
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 180 (02) : 538 - 538
  • [33] The Bioinformatics Analysis of miRNAs Signatures Differentially Expressed in HER2(+) Versus HER2(-) Breast Cancers
    Nie, Weiwei
    Jin, Lei
    Wang, Yanru
    Wang, Zexing
    Guan, Xiaoxiang
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2013, 28 (01) : 71 - 76
  • [34] Impacts of HER2 immunohistochemical scores on response and outcomes of HER2-positive breast cancers after neoadjuvant therapy
    Chiu, Yun-Ning
    Hsu, Chih-Yi
    Lien, Pei-Ju
    Chao, Ta-Chung
    Liu, Chun-Yu
    Lin, Yen-Shu
    Wang, Yu-Ling
    Tsai, Yi-Fang
    Tseng, Ling-Ming
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2023, 86 (04) : 409 - 417
  • [35] HER2 0, HER2 1+and HER2 2+/FISH Negative Primary Breast Cancers Are Biologically Distinct
    Donahue, Nolan
    Aragao, Alessa
    Gordezky, Rachel
    Haddad, Sandra
    Tang, Ping
    LABORATORY INVESTIGATION, 2024, 104 (03) : S146 - S148
  • [36] New ASCO/CAP guideline recommendations for HER2 testing increase the proportion of reflex in situ hybridization tests and of HER2 positive breast cancers
    N. Tchrakian
    L. Flanagan
    J. Harford
    J. M. Gannon
    C. M. Quinn
    Virchows Archiv, 2016, 468 : 207 - 211
  • [37] Analysis of HER2 amplification and IGF-IR expression in CETCs and its possible association with resistance to trastuzumab in HER2 positive breast cancers
    Zimon, D.
    Pizon, M.
    Pachmann, U.
    Pachmann, K.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S76 - S76
  • [38] Changes in the positive rate of HER2 expression may indicate the progression of early breast cancer
    Han, D.
    Yue, M.
    Zhao, M.
    Liu, Y.
    VIRCHOWS ARCHIV, 2021, 479 (SUPPL 1) : S70 - S70
  • [39] New ASCO/CAP guideline recommendations for HER2 testing increase the proportion of reflex in situ hybridization tests and of HER2 positive breast cancers
    Tchrakian, N.
    Flanagan, L.
    Harford, J.
    Gannon, J. M.
    Quinn, C. M.
    VIRCHOWS ARCHIV, 2016, 468 (02) : 207 - 211
  • [40] Response to anti-HER2 neoadjuvant chemotherapy in HER2-positive invasive breast cancers with different HER2 FISH patterns
    Lv, Hong
    Bai, Qian-Ming
    Li, Ming
    Cai, Meng-Yuan
    Zhou, Shu-Ling
    Liu, Yin
    Wang, Zhong-Hua
    Shui, Ruo-Hong
    Lu, Hong-Fen
    Xu, Xiao-Li
    Yu, Bao-Hua
    Tu, Xiao-Yu
    Bi, Rui
    Cheng, Yu-Fan
    Zhou, Xiao-Yan
    Shao, Zhi-Min
    Yang, Wen-Tao
    JOURNAL OF CLINICAL PATHOLOGY, 2024,
12345